CXCL12 and Miyoshi myopathy: Inhibition of Cx43 GJIC by the non-specific GJIC inhibitors heptanol or 18α-glycyrrhetinic acid significantly attenuates CXCL12 secretion by BMSC, and augments bortezomib induced MM cell apoptosis [164,165] (Table 1).